Assessment of Morbidity and Mortality Following Serratus Anterior Plane Block (SAPB) for Unilateral Rib Fractures
Albert Einstein College of Medicine
220 participants
Aug 10, 2025
OBSERVATIONAL
Conditions
Summary
The goal of this observational study is to learn about the long-term effects of the serratus anterior plane block (SAPB) in adult patients who suffered multiple unilateral anterolateral rib fractures within 24 hours of patient presentation to the emergency department. The main question it aims to answer is: Does the SAPB for multiple anterolateral rib fractures demonstrate reduction in patient morbidity and mortality, including incidence of pneumonia, length of hospital stay, discharge disposition, and death, as compared to standard analgesic regimens. The SAPB will be performed if a physician trained in the SAPB is available within 24 hours of injury. If a trained physician is not available and the patient meets inclusion criteria, they will receive parental analgesia with opioid therapy. They will be followed until date of hospital discharge, up until 60 days.
Eligibility
Inclusion Criteria5
- Patients over 18 years of age being treated in the Emergency Department at Jacobi Medical Center
- Presenting within 24 hours of injury
- Patient with 2 or more unilateral, anterior or lateral rib fractures
- Able to provide consent (patient or health care proxy)
- Clinical team believes the patient will require inpatient admission at the time of enrollment
Exclusion Criteria9
- Patients in traumatic arrest or hemodynamic instability
- Patient expected to be discharged from the hospital within 24 hours
- Prisoner
- Pregnancy
- Children less than 18 years of age
- The patient is known or is suspected to be allergic to anesthetic
- Significant pain from another traumatic and distracting injury
- Patients without the ability to consent (or no health care proxy to consent)
- Patients with bilateral or posterior rib fractures
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT07032766